AWS GraphRAG cuts drug R&D time by 87%

AWS deployed a GraphRAG system that unified scattered proprietary databases and public research into a single, queryable knowledge graph, reducing pharmaceutical research and development cycle time by 87 percent. Researchers can run natural-language queries against a verified store that combines internal records with external literature.

The setup ingests unstructured files from public repositories such as PubMed alongside internal laboratory notes, engineering records and clinical metrics. Amazon Comprehend Medical extracts standard medical codes from raw text. Amazon Bedrock running Anthropic’s Claude 4.5 Sonnet generates document summaries and ranks topical relevance. Processed data elements flow through AWS Lambda and are bulk-loaded from Amazon S3 into Amazon Neptune Analytics, where information is structured as nodes and edges representing entities, publications, authors, classifications and text segments.

The GraphRAG execution layer links the user interface to the graph. A Knowledge Graph Linker uses fuzzy string indexing to map natural language inputs to graph nodes. An EntityLinker aligns prompt terms with the underlying schema. A BedrockGenerator then drafts responses grounded in graph content. Long documents are broken into indexed chunks and anchored to established taxonomies and diagnostic metrics. For each answer, the system displays the graph traversal steps and returns citations tied to specific source nodes.

Early adopters report that initial discovery phases that previously required more than six months now finish in about three weeks. Data retrieval speeds improved by roughly 85 percent, and research review times fell by about 70 percent thanks to automated citation mapping and source verification. Institutional knowledge such as past experiments, failed trials and project context remains indexed in Neptune, enabling new staff to query historical decisions after personnel changes.

Unifying proprietary datasets with open-access sources introduces data normalization challenges. Inconsistent formats and terminology can cause inaccurate relational mappings and raise the risk of hallucinations by the language model. Deployments implement strict schema governance, classification nodes that define retrieval boundaries, configured entity matching thresholds and taxonomy mappings. Provenance nodes for author and journal records are attached to answers to support traceability.

The architecture is modular: teams can replace the language model or alter the graph structure without rebuilding the entire application. Organisations can add public databases or internal records into the graph while keeping active query interfaces running. For compliance, the graph produces evidence trails and visualizations that show how specific variables and sources were linked to a conclusion, supporting regulatory documentation requirements.

Running the solution requires cloud resource planning. An Amazon Neptune Analytics instance provisioned with 16 memory units costs about $0.48 per hour. Development environments commonly use Amazon SageMaker Jupyter notebooks on t3.medium instances. Firms must budget for dynamic token consumption from Bedrock during query processing and content generation.

Some organisations are adapting the GraphRAG deployment model outside pharmaceutical research to connect fragmented legacy systems to verified public repositories and internal records.